An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress

Metabolism: Clinical and Experimental

Volumn 52, Issue 5, 2003, Pages 586-589

  Bonnefont Rousselot, Dominique ^a,b,c   Raji, B ^a,b,c   Walrand, S ^a,b,c   Gardes Albert M ^a,b,c   Jore, D ^a,b,c   Legrand, Jore A ^a,b,c   Peynet, J ^a,b,c   Vasson, M P ^a,b,c  

^a Faculte de Pharmacie ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL GROUP; METFORMIN; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; ANTIDIABETIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; WATER;

ARTICLE; CELL STIMULATION; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RADIOLYSIS; SCAVENGING SYSTEM; GAMMA RADIATION; METABOLISM; RADIATION EXPOSURE; ULTRAVIOLET SPECTROPHOTOMETRY;

CHEMILUMINESCENT MEASUREMENTS; FREE RADICALS; GAMMA RAYS; HUMANS; HYPOGLYCEMIC AGENTS; LEUKOCYTES; METFORMIN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPECTROPHOTOMETRY, ULTRAVIOLET; TETRADECANOYLPHORBOL ACETATE; WATER;

EID: 0038410183     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50093     Document Type: Article

References (32)

1. Wiernsperger NF, Bailey CJ: The antihyperglycaemic effect of metformin. Therapeutic and cellular mechanisms. Drugs 58:31-39, 1999 (suppl 1)
2. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes Lancet 352:854-865, 1998
3. Tanaka Y, Iwamoto H, Onuma T, et al: Inhibitory effect of metformin on formation of advanced glycation end products. Curr Ther Res 58:693-697, 1997
4. Beisswenger P, Howell S, Touchette A, et al: Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48:198-202, 1999
5. Ruggiero-Lopez D, Lecomte M, Moinet G, et al: Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end products formation. Biochem Pharmacol 58:1765-1773, 1999
6. Youssef S, Nguyen DT, Soulis T, et al: Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Kidney Int 55:907-916, 1999
7. Giardino I, Edelstein D, Brownlee M: BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97:1422-1428, 1996
8. Yan SD, Schmidt AM, Anderson GM, et al: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
9. Nishikawa T, Edelstein D, Du XL et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
10. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707-727, 1999
11. Ceriello A: Oxidative stress and glycemic regulation. Metabolism 49:27-29, 2000
12. Faure P, Rossini E, Wiernsperger N, et al: An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes 48:353-357, 1999
13. Ewis SA, Abdel-Rahman MS: Effect on metformin on glutathione and magnesium in normal and stretozotocin-induced diabetic rats. J Appl Toxicol 15:387-390, 1995
14. Tessier D, Maheux P, Khalil A, et al: Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism 48:897-903, 1999
15. Pavlovic D, Kocic R, Kocic G, et al: Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2:251-256, 2000
16. Cosic V, Antic S, Pesic M, et al: Monotherapy with metformin: Does it improve hypoxia in type 2 diabetic patients? Clin Chem Lab Med 39:818-821, 2001
17. Giardino I, Fard AK, Hatchell DL, et al: Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47:1114-1120, 1998
18. Yildiz G, Demiryürek T, Sahin-Erdemli I, et al: Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 124:905-910, 1998
19. Spinks JWT, Woods RJ: Water and inorganic aqueous systems, in Introduction to Radiation Chemistry (ed 3). New York, NY, Wiley, 1990, pp 243-313
20. Yuen KH, Peh KK: Simle high-performance liquid chromatography method for the determination of metformin in human plasma. J Chromatogr B 710:243-246, 1998
21. Caldefie-Chezet F, Poulin A, Tridon A, et al: Leptin: A potential regulator of polymorphonuclear neutrophil bactericidal action. J Leukoc Biol 69:414-418, 2001
22. .- produits par radiolyse continue de l'eau J Chim Phys 97:283-288, 1997
23. .- free radicals. Radiat Res 153:497-507, 2000
24. Pabst MJ: Priming of neutrophils, in Hellwell PG, William TJ (eds): The Handbook of Immunopharmacology: Immunopharmacology of Neutrophils. San Diego, CA, Academic, 1994, pp195-222
25. phox phosphorylation in human neutrophils. J Immunol 165:5238-5244, 2000
26. Casimiri CM, Teahan CG: The respiratory burst of neutrophils and its deficiency, in Hellewell PG, William TJ (eds): The Handbook of Immunopharmacology: Immunopharmacology of Neutrophils. San Diego, CA, Academic, 1994, pp 27-54
27. Karlsson A, Nixon JB, McPhail LC: Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: Dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol 67:396-404, 2000
28. Hasan K, Heesen BJ, Corbett JA, et al: Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249:101-106, 1993
29. Wiernsperger NF: Metformin: Intrinsic vasculoprotective properties. Diabetes Technol Ther 2:259-272, 2000
30. Detaille D, Wiernsperger N, Devos P: Cellular and molecular mechanisms involved in insulin's potentiation of glycogen synthase activity by metformin. Biochem Pharmacol 58:1475-1486, 1999
31. Detaille D, Gingas B, Leverve X, et al: Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol 63:1259-1272, 2002
32. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86:494-501, 2000